Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2025-07-02 00:00:00 ET · period of report 2025-06-30 · accession 0000950170-25-093035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-07-02 | 2025-06-30 | CADL | Nichols William Garrett | Chief Medical Off | M - OptEx | $1.29 | +781 | 53.3K | +1% | +$1,007 |
| DT | 2025-07-02 | 2025-06-30 | CADL | Nichols William Garrett | Chief Medical Off | S - Sale+OE | $5.04 | -781 | 52.5K | -1% | -$3,936 |
| DT | 2025-07-02 | 2025-06-30 | CADL | Nichols William Garrett | Chief Medical Off | M - OptEx | $0.00 | -781 | 30.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-30 | M | A | 781 | $1.29 | 53,274 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-30 | S | D | 781 | $5.04 | 52,493 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-06-30 | M | D | 781 | $0.00 | 30,314 | D | $1.29 · — to 2033-04-28 | 781 Common Stock | (F2) This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date. |